Clinical characteristics of breast cancer patients admitted to academic surgical wards in Tehran, Iran: an analytical cross-sectional study.
Breast Cancer
Cross-Sectional study
Iran
Multicenter study
Prevalence
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
25 09 2023
25 09 2023
Historique:
received:
10
06
2023
accepted:
06
09
2023
medline:
26
9
2023
pubmed:
25
9
2023
entrez:
24
9
2023
Statut:
epublish
Résumé
Breast cancer (BC) is the most commonly diagnosed cancer and the leading cause of cancer death among women. Knowledge of the clinical characteristics of BC in a population may be informative for disease prediction or diagnosis and for developing screening and diagnostic guidelines. This study aimed to evaluate the clinical characteristics of female patients with BC who were admitted to academic surgical wards in Tehran, Iran. In this cross-sectional study, demographic information and clinical characteristics of Iranian females with BC who had undergone breast surgery from 2017-2021 in four academic Breast Surgery Units were extracted from medical files and recorded via a pre-designed checklist. A total of 1476 patients with a mean age of 48.03 (± 11.46) years were enrolled. Among them, 10.4% were aged less than 35. In younger patients, Triple-negative and Her2-enriched subtypes of BC were significantly higher compared to older ones. Overall, 85.7% of tumors were invasive ductal carcinoma, 43.3% were grade 2, 41.4% were located in the UOQ, and 65.2% had presented with mass palpation. The mean pathologic tumor size was 28.94 mm, and the most common subtype was luminal B. Many characteristics of breast cancer in this study were similar to other countries and previous studies in Iran. However, a higher proportion of young BC compared with Western countries, and even with older studies in Iran, suggest a trend toward lower age for BC in recent years. These results indicate the need for preventive measures and screening in Iranian women at a younger age.
Sections du résumé
BACKGROUND
Breast cancer (BC) is the most commonly diagnosed cancer and the leading cause of cancer death among women. Knowledge of the clinical characteristics of BC in a population may be informative for disease prediction or diagnosis and for developing screening and diagnostic guidelines. This study aimed to evaluate the clinical characteristics of female patients with BC who were admitted to academic surgical wards in Tehran, Iran.
METHODS
In this cross-sectional study, demographic information and clinical characteristics of Iranian females with BC who had undergone breast surgery from 2017-2021 in four academic Breast Surgery Units were extracted from medical files and recorded via a pre-designed checklist.
RESULTS
A total of 1476 patients with a mean age of 48.03 (± 11.46) years were enrolled. Among them, 10.4% were aged less than 35. In younger patients, Triple-negative and Her2-enriched subtypes of BC were significantly higher compared to older ones. Overall, 85.7% of tumors were invasive ductal carcinoma, 43.3% were grade 2, 41.4% were located in the UOQ, and 65.2% had presented with mass palpation. The mean pathologic tumor size was 28.94 mm, and the most common subtype was luminal B.
CONCLUSIONS
Many characteristics of breast cancer in this study were similar to other countries and previous studies in Iran. However, a higher proportion of young BC compared with Western countries, and even with older studies in Iran, suggest a trend toward lower age for BC in recent years. These results indicate the need for preventive measures and screening in Iranian women at a younger age.
Identifiants
pubmed: 37743485
doi: 10.1186/s12905-023-02637-0
pii: 10.1186/s12905-023-02637-0
pmc: PMC10518944
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
511Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Asian Pac J Cancer Prev. 2015;16(12):5049-52
pubmed: 26163639
Breast Cancer Res Treat. 2010 Jan;119(1):193-200
pubmed: 19350387
JAMA Surg. 2015 Jan;150(1):9-16
pubmed: 25408966
Asian Pac J Cancer Prev. 2022 Dec 01;23(12):4109-4117
pubmed: 36579992
Breast Dis. 2015;35(2):95-102
pubmed: 25736840
Asian Pac J Cancer Prev. 2014 Jan;14(11):6529-32
pubmed: 24377562
Ann Med Surg (Lond). 2019 Apr 02;41:47-52
pubmed: 31245000
BMC Cancer. 2010 May 21;10:223
pubmed: 20492711
BMC Cancer. 2005 Apr 05;5:35
pubmed: 15811187
J Cancer Res Clin Oncol. 2013 Apr;139(4):617-23
pubmed: 23269487
PLoS One. 2022 Sep 12;17(9):e0269732
pubmed: 36094928
Int J Breast Cancer. 2019 Jul 1;2019:8536548
pubmed: 31355003
Clin Cancer Res. 2019 Mar 15;25(6):1970-1979
pubmed: 30559169
J Nucl Med. 2005 Sep;46(9):1455-9
pubmed: 16157527
Int J Breast Cancer. 2020 May 01;2020:1963814
pubmed: 32411480
Cancer Causes Control. 2004 Sep;15(7):637-45
pubmed: 15280621
Int J Surg. 2014;12(5):394-8
pubmed: 24657350
Arch Iran Med. 2019 Jul 01;22(7):355-360
pubmed: 31679377
Updates Surg. 2017 Sep;69(3):313-317
pubmed: 28260181
Breast J. 2012 Jul-Aug;18(4):318-25
pubmed: 22607016
Breast. 2011 Apr;20 Suppl 2:S75-80
pubmed: 21316967
Int J Cancer. 2003 Jul 1;105(4):542-5
pubmed: 12712447
Iran J Public Health. 2018 Mar;47(3):309-316
pubmed: 29845017
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
BMC Res Notes. 2012 Jul 25;5:376
pubmed: 22830453
J Clin Oncol. 1994 May;12(5):888-94
pubmed: 8164038
Breast Cancer. 2011 Oct;18(4):292-8
pubmed: 20571962
BMC Cancer. 2019 Nov 12;19(1):1091
pubmed: 31718602
Medicine (Baltimore). 2015 Aug;94(32):e1359
pubmed: 26266392
Histopathology. 2020 Aug;77(2):181-185
pubmed: 32056259
BMC Womens Health. 2011 Sep 30;11:44
pubmed: 21961708
Cancer Commun (Lond). 2018 Jun 26;38(1):39
pubmed: 29941044
Clin Breast Cancer. 2018 Oct;18(5):e1045-e1052
pubmed: 29941391
Am J Surg. 2008 May;195(5):641-4
pubmed: 18424280